Brainlab AG Sets IPO Price Range for Market Debut

Brainlab AG, a medtech software pioneer, has established its IPO price range between EUR 80.00 and EUR 100.00 per share, targeting a market capitalization between EUR 1.67 billion and EUR 2.09 billion. The offering involves 2 million new shares from a capital increase and up to 3.2 million secondary shares from existing holders. This aims to achieve a free float of up to approximately 26.6%.

The generated proceeds of up to EUR 200 million will support Brainlab's commercialization efforts and expansion into new markets. The IPO offer, starting June 24 and closing July 1, 2025, requires the approval from BaFin, with the trading debut scheduled for July 3, 2025, on the Frankfurt Stock Exchange.

Brainlab plans to accelerate growth by investing in technology and expanding its product range. Founder Stefan Vilsmeier emphasizes their commitment to transforming healthcare through digital innovations.